VEGFA and glioblastoma: However, anti-VEGF drugs were able to alleviate the glioblastoma-related brain edema in both mice and patients (214, 215), offering a strong rationale for combining low-dose anti-VEGF therapy with immunotherapy in particular ICB therapy for potentially reducing the brain metastasis as well as ameliorating the side effects.